With fellows from the Singapore-Stanford Biodesign Programme, where I met my co-founders for Privi, Including Prusothman Raja (extreme right), Benjamin Tee (first row, second from right) and Cecilia Wang (top row, right) // Credit: Rena DharmawanThe year after, I took part in a hackathon, and was fortunate enough to meet my co-founders for the second startup I was involved in, Jaga-Me. We came up with a service to match elderly patients requiring home care with certified care aides and nurses.
The satisfaction hits me when my product finally reaches market. In the process, I learnt that I needed to have resilience, to be gung-ho, to push my project all the way.
It’s about figuring it out and hustling. No one is going to tell you how to do it. You need to go and figure it out yourself. Eventually, you will get there.
But it’s not going to be an easy journey. At times, it’s quite a lonely road. You will meet naysayers. But perhaps it’s the rebellious streak in me that pushes me to go on. If you say “cannot do”, I will say “can do”.
And that was one of the reasons why I started the Duke-NUS Health Innovator Programme (DHIP) in 2023, a first-of-its-kind programme in Singapore that assembles a multidisciplinary student team to work on an unmet clinical need, while being closely mentored by dedicated industry and clinical mentors.
I wanted to guide students who are keen on healthcare innovation, to provide them with more support. Now into our fourth year, we’ve seen DHIP expand and becoming a launchpad for more collaborations.
But there is so much more potential to it. Using DHIP, I applied for a fellowship that gathers outstanding mid-career leaders from the region and invites them to the United States to develop a project and launch dynamic collaborations with their American counterparts.
In December 2024, I found out that I had been accepted. From October, I’ll be spending 1.5 months in the US as part of the Eisenhower Fellowships 2025 Southeast Asia Programme.
I aim to visit top academic medical and research institutions in the US, especially in areas where universities, hospitals and major healthcare companies have close relationships. I hope the interactions that result will help us to increase the number of private-public collaborations between academia, hospitals and the med tech industry. Focusing on nurturing innovation talent, we hope to co-develop better medical devices and establish a shorter pathway to commercialise new technologies.
Moving forward, I hope to develop DHIP through even more systemic partnerships in Singapore and our Southeast Asian region, so we not only train our students well to meet manpower needs but also help address industry pain points.
We are now looking at the sustainability of the programme, whether we can get revenue from various sources, such as securing sponsorships from corporations. We also have hopes for DHIP to expand regionally, perhaps in the form of short courses targeting learners who wish to access the innovation ecosystem in our region.